Biography and Research Information
OverviewAI-generated summary
Robin Eluvathingal's research focuses on investigating methods to enhance the effectiveness of cancer treatments. This work includes studying the radiosensitization of pancreatic cancer through the targeting of Cyclin-Dependent Kinase 1, as detailed in a 2023 publication. Another area of investigation involves examining the radiosensitizing effects of methionine restriction on KRAS mutant rectal cancer, also presented in 2023. Eluvathingal has co-authored two publications, collaborating with researchers such as Stetson Van Matre, Nükhet Aykin‐Burns, Isabelle R. Miousse, and Oscar Zuniga.
Metrics
- Publications: 2
Selected Publications
-
Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer (2023)
Collaboration Network
Top Collaborators
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
Similar Researchers
Based on overlapping research topics